Introduction
Over the last few decades of the twentieth century, the mouse became the animal model of choice for the study of the various aspects of mammalian development, physiology and physiopathology. Apart from being the easiest and cheapest laboratory mammal to maintain, its genetic map is very well known, and many inbred strains (the genetic background of which is defined and identical for all the individuals) as well as mutant strains are available. Furthermore, sequencing of the whole murine genome is almost complete, giving access in principle to all the genes present in the genome. It has been possible since the early 1980s to introduce experimentally new genetic information in the mouse germ line, giving rise to 'transgenic' mice. Finally, and this is unique to the mouse among mammals, the methods for creating transgenic mice have been refined in such a way that it has become possible to create mice bearing a whole range of programmed genetic modifications, including null mutations as well as other types such as not only point mutations, but also alterations at the chromosome level, for example large deletions or translocations. Taken as a whole, the transgenic approach has revolutionized the study of all aspects of mammalian genetics and biology.
Generation of Transgenic Mice
Transgenic mice by DNA microinjection into the pronucleus of the zygote
The first route to generate transgenic mice consists in directly injecting a cloned deoxyribonucleic acid (DNA) of choice (the transgene) into one pronucleus of a fertilized egg. This procedure (Figure 1) gives rise, after reimplantation into a foster mother, to mice in which the transgene has integrated randomly in the mouse genome, generally as tandem head-to-tail arrays of variable length. Thus neither the number of copies integrated nor the site of integration is controlled. However, this route of transgenesis is instrumental in the study of gene regulation in vivo; furthermore, it offers a means of targeting expression of a given gene product into a chosen cell or tissue type, thereby opening the way for the study of its function in physiological or pathological situations.
Transgenic mice by the use of embryonic stem cells
Transgenic mice may be obtained by a second route, using embryonic stem (ES) cells (Figure 2 ). These cells, which are derived directly from the culture of blastocysts, retain the remarkable ability to colonize a host embryo, including its germ line; thus previous introduction of exogenous DNA into the cultured ES cells allows one to generate transgenic mice via the production of germ-line chimeras. However, the most important virtue of the use of ES cells to make transgenic mice, in contrast to the transgene pronuclear injection, is that desirable and low-frequency genetic alterations may be selected and verified in the ES clones maintained in culture and then reintroduced in the animal. Thus, for any mutation introduced in ES cells in vitro, the corresponding mutated mouse may be obtained and the phenotypic effects of the mutation studied in detail in the context of the living embryo or animal. Such a scenario has been extremely fruitful for the study of gene function in mammals (Capecchi, 1989 generated by pronuclear microinjection offer a unique opportunity to address this question. Indeed, transgene expression can be monitored in any type of cell, at any time of embryonic and postnatal development. Thus, different versions of a given gene may be used to generate transgenic mice, thereby allowing one to map the functional regions of this gene necessary for its correct regulation. This approach was applied for the first time to elastase gene expression in the cells of the exocrine pancreas, and it was shown that a 134-bplong sequence was necessary and sufficient for proper temporal and spatial regulation of the gene (Hammer et al., 1987) . Since then, such a strategy has been applied successfully to many other genes (reviewed by Macdonald and Swift, 1998) . Despite these achievements, it should be noted that analyses of transgene regulation may be obscured by the random character of the integration site; thus the genomic sequences flanking the transgene may result in its enhanced, repressed or even inappropriate expression. This is referred to as a 'position effect' (Wilson et al., 1990) . Finally, it is generally observed that transgene expression is not proportional to copy number. These observations point to the necessity of analyzing several independent transgenic lines to draw conclusions about the in vivo regulation regions of any gene (Macdonald and Swift, 1998) . Interestingly, specific DNA sequences called locus control regions (LCRs) have been identified in the vicinity of some genes that render transgene expression proportional to the number of copies and independent of the insertion site (Grosveld, 1999) . Finally, it should be noted that it is possible to buffer the position effect by using large transgenes such as yeast or bacterial artificial chromosomes (YACs and BACs) which encompass from 100 kb up to 2 Mb (reviewed by Giraldo and Montoliu, 2001) .
Having defined the regulatory sequences that control specific gene expression, it is then possible to fuse them to the coding sequences of any gene of interest, resulting in a 'hybrid transgene'. Depending on the regulatory sequences used and the coding Figure 1 Generation of transgenic mice by DNA microinjection into the pronucleus of the zygote. A DNA solution is injected (1) into the pronucleus of a zygote. Injected eggs are then reimplanted into a foster mother (2, 3). In a proportion of cases, the injected DNA integrates into the chromosomes of the zygote. The integrated exogenous DNA (the transgene) is transmitted through cell division to all the cells of the mouse born from the injected zygote, giving rise to a transgenic mouse. The presence of the transgene in the host DNA is monitored by Southern blot, using a radioactive probe that specifically recognizes the injected DNA (4, 6). Crossing of transgenic founders (F 0 ) with a nontransgenic mouse will give rise to F 1 progeny, half of which are heterozygous for the transgene (5, 6). F 1 intercrosses (7) allow the experimenter to obtain mice homozygous for the transgene, therefore generating a line of transgenic mice. sequence fused to it, enhanced or ectopic expression of either the normal gene or a modified one can be obtained in transgenic mice. Such a strategy is extremely versatile (Figure 3 ) and has been widely used, for example to address the biological function of a given protein. It may also allow the creation of murine models of human diseases, for example, the role of oncogenes in malignant transformation.
Knockout and knockin
The availability of ES cells and the design of methods using homologous recombination (HR) to alter a given gene has allowed scientists to extend considerably the use and interest of transgenesis in the mouse. Indeed, it has become possible to create mice with a mutation specifically in a given gene: the phenotypic analysis of the mutant embryo or mouse will then give insight into the function of this gene. The general scenario of targeted mutagenesis by HR in ES cells (outlined in Figure 2 ) was first used either to introduce or to correct null mutations in the Hprt gene; indeed, in this particular case, the mutated or corrected ES cells could be directly selected by the use of appropriate drugs.
HR between an incoming DNA and the homologous sequence in the genome is a rare event, as compared with random insertion. Thus, appropriate targeting vectors and methods of selection were devised to achieve and select HR events and produce ES cells with an altered gene. The most frequently produced alteration is gene disruption, commonly called knockout (KO; Figure 4a ). Once the mutated ES clones have been generated, mice bearing the mutation can be obtained via the generation of chimeras ( Figure 2) . The ability to generate knockout mice has been widely used and more than 1000 genes have been disrupted by HR in ES cells and the corresponding mutated mice generated, illuminating the function of genes in embryonic development as well as in the various (muscular, hematopoietic, nervous, immunological, etc.) biological systems of the mouse. A very interesting extension of the KO approach, the 'knockin', consists of introducing in the targeting vector the coding sequences of a gene of interest in-frame with those of the endogenous gene. After HR, the modified gene will express the gene of interest, precisely under the control of the promoter and regulatory sequences of the targeted gene, thus avoiding the position effect encountered in transgenesis by pronuclear microinjection (Figure 4b) . The gene of interest may be, for example, a reporter gene, coding for proteins such as E. coli beta galactosidase or green fluorescent protein, whose activity is easily visualized and therefore enables determination of the pattern of a given gene even at the cellular level. Another interesting use of knockin deals with genes that have several homologs in the mouse genome but have overlapping or different patterns of expression and the disruption of which generates different phenotypes. Knocking in a complementary DNA (cDNA) of a given homolog into another homolog will make it possible to determine if the proteins encoded by the two genes can replace each other and therefore have a similar biological function.
Gene targeting: subtle mutations and chromosomal rearrangements
While gene disruption is a valuable tool to address gene function, more subtle alterations are needed to refine the genetic analysis and also to create models of human genetic disease, which are frequently caused by subtle mutations resulting in the synthesis of an abnormal protein. However, in this case the presence of the selection cassette in the mutated allele may interfere with the normal regulation and expression of the targeted gene. Methods have therefore been devised to generate a mutated allele devoid of foreign sequences (see Figure 5) . One method relies on a hypoxanthine phosphoribosyl transferase (HPRT)-based selection system (Figure 5a , 5b) and has allowed, for example, the generation of mice bearing various point mutations in the prion protein Prnp gene (Barron et al., 2001) . The other method (Figure 5b) takes advantage of the properties of an enzyme, the Cre recombinase, isolated from the bacteriophage P1 (Figure 6a, 6b) . The end result is a modified allele carrying the mutation and one loxP site as the only foreign sequence (e.g. the generation of a point mutation in the fibroblast growth factor receptor 3; Wang et al., 1999) .
Use of the Cre-loxP system has been extended, in combination with gene targeting, to the generation of chromosomal rearrangements (large deletions, inversions, duplications and translocations; Figure 6c, 6d) . Chromosomal abnormalities are frequently involved in human fetal loss and in various types of tumors. The hybrid transgene is constructed in such a way that the protein of interest will be synthesized in a tissue from which it could be extracted and purified, for example resulting in the extraction of milk or blood. Owing to its small size, the mouse serves only as a model system for bigger animals, for example farm animals. Creating those types of chromosomal rearrangements in the mouse is therefore a very valuable tool to dissect the molecular mechanisms underlying the defects they induce. Furthermore, large deletions could generate segmental haploidy in the diploid mouse genome, facilitating the detection of recessive mutations in the deleted regions (reviewed by Yu and Bradley, 2001 ).
The Cre-loxP system and conditional mutagenesis
As emphasized in the previous section, the generation of KO mice is extremely important in the study of gene function. However, this approach has some limitations: first, a mutation that induces lethality at a given stage of development precludes the study of gene function later in development; second, when a gene has a complex pattern of expression, namely in several cell types or tissues, analysis of its function, based on the effects of a mutation present in all the cells of the organism, might become extremely difficult. To overcome these problems, strategies have been developed that are based on the Cre-loxP system (Figure 7 ; reviewed by Sauer, 1998) . Two requirements need to be fulfilled for conditional targeting with the Cre-loxP system: (a) a 'floxed' allele must be created in such a way that two loxP sites flank an essential region of the gene, without altering its normal activity; (b) targeting of Cre expression must be tightly controlled: to If the two loxP sites have the same orientation, the DNA region situated between these sites is deleted during recombination. This type of configuration is used to create mutations devoid of the selection cassette (see Figure 5 ), deletions and conditional mutations (see Figure 7) . If the orientation of the two loxP sites is opposed, recombination leads to the inversion of the region comprised between the two sites. (d) Recombination in trans. If one loxP site is integrated in the genome and the other is carried by a circular plasmid, there may be an insertion of sequences carried by the plasmid in the integrated loxP site. However, since the insertion is a rare event compared with deletion (i.e. the reverse reaction), this type of event requires the use of mutant loxP sites. When the loxP sites are both integrated in the genome, recombination in trans induces chromosomal rearrangements: deletions, duplications or translocations. Such recombination events are rare and have to be selected to be revealed. To do so, one can use truncated and nonfunctional hp-loxP and loxP-rt selection cassettes. After recombination between the loxP sites, and only in this case, a functional hp-loxP-rt cassette (the remaining loxP site is situated in an intron) is reconstituted, thus allowing selection of the chromosomal rearrangement desired (see legend to Figure 5) . Furthermore, the relative orientation of loxP sites compared with the centromeric-telomeric axis of the chromosomes is important. Indeed, in the case of wrong relative orientation, recombination will result in the formation of acentric or dicentric chromosomes, which, in view of their great instability, will be eliminated and induce cell death.
that end, either transgenic mice by pronuclear microinjection or, better, knockin mice may be used. This scenario allows spatial control of the occurrence of a mutation and therefore insight into the function of a gene in a particular cell type or tissue. It has also proved to be instrumental in the creation of animal models of human disease. For example, transgenic mice were created in which disruption of the tumor suppressor gene Brca1 was specifically induced in the epithelial cells of the mammary gland, therefore furnishing a model for the study of BRCA1 (breast cancer 1, early onset) in breast cancer (Xu et al., 1999) . This could not have been possible without the use of a conditional approach, since homozygous null mutations in this gene result in embryonic lethality. A further refinement of the floxed gene approach relies on the production of fusion protein containing Cre and the ligand-binding domain (LBD) of a steroid receptor. In such chimeric proteins, the activity of Cre becomes hormone-dependent. Therefore, recombination between loxP sites could be induced in cells expressing the chimeric Cre by injection of the appropriate ligand into mice carrying floxed alleles and a fusion transgene expressing the Cre-LBD fusion protein. In this way, the occurrence of a mutation can be controlled, not only in a spatial but also in a temporal way (reviewed by Metzger and Feil, 1999) .
Conclusion
There has been extraordinary development and refinement of the approaches allowing germ-line modification in the mouse. Indeed, almost any genetic alterations (null and point mutations, as well as chromosome rearrangements) may be introduced precisely and deliberately into the mouse genome. More recently, new approaches have been devised that allow control of the occurrence of a particular genome alteration, both spatially and temporally. No doubt the sophistication of the strategies of genomic engineering will increase in the next years, further establishing the mouse as a unique model for the study of mammalian development, physiology and physiopathology.
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Cre-lox Inducible Gene Targeting Step 1
Step 2 Step 1: the targeting construct contains three lox P sites in the same orientation, sites 1 and 2 flanking an essential region of the target gene (here an exon), and sites 2 and 3 flanking the neo selection cassette.
Step 2: transient expression of the Cre recombinase in the targeted cell results in three types of alleles: (1) type I contains the deletion, the phenotype of which can be assessed in vivo after transferring the mutation back into the animal; (2) type II corresponds to the 'floxed allele'. In vivo deletion can be obtained by crossing mice carrying this allele with Cre-expressing transgenic mice; shown is a scenario that results in the disruption of the floxed gene, specifically in neurons; (3) the third allele can also be recovered but usually has no applications. (b) Conditional gene targeting is obtained by crossing two transgenic mice. The first one (mouse A) carries two 'floxed' alleles of a given gene (type II, see (a)) and exhibits no phenotype (only one allele is shown). The second one (mouse B) is a transgenic mouse for a hybrid transgene corresponding to the Cre recombinase coding sequence under the control of the cis-acting regulatory elements of a tissue-specific promoter (here a neuron-specific gene, P neuron ). In the progeny, only neurons express the Cre recombinase and consequently harbor deleted (type I, see (a)) allele; all other cells retain the active 'floxed' allele. Consequences of the absence of the target gene in neurons can therefore be assessed. Function of the target gene in other cell types could be addressed by crossing the first mouse with another transgenic mouse expressing the Cre under the control of an appropriate promoter.
